| RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
3.64 |
Evidence |
|
| QARS |
QARS: Glutaminyl-tRNA synthetase |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
3.64 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
3.64 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
3.64 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
3.64 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
RELA |
RELA, NFKB3: Transcription factor p65 |
3.64 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
3.64 |
Evidence |
|
| BRD2 |
BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.64 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
QARS |
QARS: Glutaminyl-tRNA synthetase |
3.64 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
GNB1 |
GNB1: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
3.64 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
ZFP36 |
ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline |
3.64 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
ETF1 |
ETF1, ERF1, RF1, SUP45L1: Eukaryotic peptide chain release factor subunit 1 |
3.64 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
3.64 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
3.64 |
Evidence |
|
| ZNF217 |
ZNF217, ZABC1: Zinc finger protein 217 |
CSK |
CSK: Tyrosine-protein kinase CSK |
3.64 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
3.64 |
Evidence |
|
| DHX16 |
DHX16, DBP2, DDX16, KIAA0577: Putative pre-mRNA-splicing factor ATP-dependent RN |
CSK |
CSK: Tyrosine-protein kinase CSK |
3.64 |
Evidence |
|
| PLSCR1 |
PLSCR1: Phospholipid scramblase 1 |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
3.64 |
Evidence |
|
| BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
3.64 |
Evidence |
|
| DDX3X |
DDX3X, DBX, DDX3: ATP-dependent RNA helicase DDX3X |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.64 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
3.635 |
Evidence |
|
| ANAPC11 |
ANAPC11, HSPC214: Anaphase-promoting complex subunit 11 |
ANAPC2 |
ANAPC2, APC2, KIAA1406: Anaphase-promoting complex subunit 2 |
3.632 |
Evidence |
|
| ROBO3 |
ROBO3: Roundabout homolog 3 precursor |
ROBO2 |
IPI00385980 |
3.632 |
Evidence |
|
| UBE2D2 |
UBE2D2, UBC4, UBCH5B: Ubiquitin-conjugating enzyme E2 D2 |
ANAPC11 |
ANAPC11, HSPC214: Anaphase-promoting complex subunit 11 |
3.632 |
Evidence |
|
| CLTCL1 |
CLTCL1, CLH22, CLTCL, CLTD: Clathrin heavy chain 2 |
GGA2 |
GGA2, KIAA1080: ADP-ribosylation factor-binding protein GGA2 |
3.632 |
Evidence |
|